Psyence Biomedical Ltd. (PBM)
(Delayed Data from NSDQ)
$4.95 USD
+0.41 (9.03%)
Updated Aug 5, 2025 04:00 PM ET
After-Market: $4.75 -0.20 (-4.04%) 7:58 PM ET
NA Value
NA Growth NA Momentum NA VGMFundamental Charts
About Dividend Yield (TTM)
Psyence Biomedical Ltd.'s dividend yield currently sits at 0%, which is in-line with the Medical - Biomedical and Genetics industry's yield of 0.00%.
The company's trailing twelve month (TTM) Dividend Yield calculates the indicated annual dividend divided by the stock price. This value is always expressed as a percentage. This is the return on investment that is specifically attributed to the expected dividends that are paid out over a year. Note: investors should not base their investments on the size of the dividend yield alone. Seek attractive dividend yields, but only on top rated stocks with a solid payment history.
PBM 4.95 +0.41(9.03%)
Will PBM be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for PBM based on the 1-3 month trading system that more than doubles the S&P 500.
Other News for PBM
12 Health Care Stocks Moving In Monday's Intraday Session
Dow Jumps 1%; Tyson Foods Earnings Beat Views
PBM Advances in Psilocybin Study and Strengthens Financial Position
Corporate Update, August 2025 | PBM Stock News
Psyence Biomedical issues letter to shareholders